Most users regain some of the lost weight if they discontinue treatment without a maintenance plan
The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
Excess histamine can also impact the motility of smooth muscle in the intestinal lining, resulting in diarrhea, constipation, bloating, and food reactivity
Tool: Monitoring for Skin Cancer, Moles, Annual Exams 02:36:28 HPV, Cancer & Warts
The work adds to growing evidence that GLP-1 drugs may have benefits beyond weight loss, and it sharpens the search for new osteoarthritis treatments that target metabolism inside the joint
This could democratize detachment: why suffer in silence when science offers relief
